SPH Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212
“Sopharma” AD (the Company) notifies that in pursuance of a decision of the General meeting of Holders of Warrants (GMHW) held on January 26, 2024 and decision of the Board of Directors of SOPHARMA AD from a meeting held on January 26, 2024 and based on art. 195 and art. 196 of the Commercial Law (CL), art. 113, para. 2, item 2 of Law on public offering of securities (LPOS) and art. 25 of the Articles of incorporation of the company a procedure for capital increase was launched for issuing up to 7 133 264 ordinary registered dematerialized freely transferable shares with a nominal value of BGN 1 each and issue value of BGN 4.13 for one share, under the condition that the shares of the increase are subscribed by the holders of warrants of issue with ISIN BG9200001212, in accordance with the terms and conditions described in the Prospectus for Public Offering of Warrants, confirmed by a Decision of the Financial Supervision Commission (FSC) No 804-E / 04.11.2021.
Data | Tytuł | Kurs | Zmiana |
---|
2024-04-25 | SPH Publication of Annual consolidated audited financial report of "Sopharma" AD for 2023 in ESF format | 13,05 | 0,00 |
2024-04-22 | SPH Sales revenues of Sopharma AD for March 2024 | 13,70 | 0,00 |
2024-04-01 | SPH Presentation of the Annual Audited Individual Financial Statements of “Sopharma” AD as at 31 December 2022 | 13,40 | 0,00 |
2024-03-20 | SPH Sales revenues for February 2024 | 14,40 | -3,13 |
2024-03-12 | SPH Incoming transfer from capital increase subject to exercise of warrants from issue BG9200001212 | 14,00 | -1,43 |
2024-03-11 | SPH Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 08 March 2024 on the acquisition of shares from a capital increase | 13,80 | +1,45 |
2024-02-29 | SPH Consolidated financial report as of 31 December 2023 | 13,70 | -2,19 |
2024-02-27 | SPH Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212 | 13,40 | +2,99 |
2024-02-22 | SPH Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the acquisition of shares from a temporary issue/exercise of warrants | 13,75 | -0,73 |
2024-02-22 | SPH Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the exercise of warrants in a capital increase under the condition | 13,75 | -0,73 |